Enjoy complimentary customisation on priority with our Enterprise License!
The Stool Testing Market size is estimated to grow by USD 445.95 million at a CAGR of 5.92% between 2023 and 2028.
Stool testing market Share
For More Highlights About this Report, Download Free Sample in a Minute
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
One of the key factors driving the stool testing market growth is the increasing prevalence of CRC. One of the most common cancers prevailing across the globe is CRC. In addition, several factors that can possibly increase an individual risk of CRC include overweight or obesity, lack of physical activity, smoking, excessive alcohol consumption, unhealthy food intake, personal history of being encountered with colorectal polyps, and inflammatory bowel disease, family history of adenomatous polyps, and type 2 diabetes.
Moreover, certain genetic conditions such as Lynch syndrome, Turcot syndrome, Muir-Torre syndrome, and juvenile polyposis syndrome have significantly increased the risk of CRC and other types of cancer. In addition, to reduce the CRC mortality rate, several screening tests, including FOBT, stool DNA test, flexible sigmoidoscopy, colonoscopy, and imaging scans, are being performed across the world with the help of government and healthcare organizations. Hence, such factors are driving the market growth during the forecast period.
A key factor shaping the stool testing market growth is the growing demand for point-of-care testing. The successful reduction in the mortality rates of CRC needs early diagnosis, early initiation of treatment, and accurate screening of individuals who are at risk of CRC. Hence, to perform these tasks, an efficient and sensitive assay is required to increase CRC screening efforts in various healthcare settings.
Moreover, the introduction of POC testing has improved the way diagnostics and clinical procedures are being performed. In addition, early diagnosis and accurate treatment of the disease are the most important strategies implemented by various stakeholders, as early detection of low-grade CRC increases the likelihood of survival, which relies on the patient's age. Therefore, technological advances in the form of low-cost rapid POC tests have transformed the diagnosis and treatment of CRC. Hence, such factors drive the market growth during the forecast period.
High treatment costs associated with GI disorders and colorectal cancer are one of the key challenges hindering the stool testing market growth. Even though the global stool testing market is growing at a rapid pace, the high costs associated with the devices used for diagnoses, such as stool testing kits and treatment of GI bleeding will negatively impact the market, especially in price-sensitive markets such as developing and emerging economies. In addition, even in developed countries, small hospitals and private physician clinics may not opt for endoscopic kits due to budget constraints.
Moreover, endoscopic kits are expensive and classified as capital items by healthcare institutions. In addition, the procurement of endoscopic devices involves many procedures and various budget allocation considerations before making the purchasing decision. Hence, such factors are negatively impacting the market. Therefore, it is expected to hinder the market growth during the forecast period.
The GI segment is estimated to witness significant growth during the forecast period. GI stool testing can be referred to as a diagnosis of digestive tract disorder, which looks for gastrointestinal disorders that appear in the stool. In addition, stool testing utilizes stool cultures to help identify pathogens (bacteria, viruses, microorganisms) present in the GI tract that cause GI distress and other systemic symptoms.
Get a glance at the market contribution of various segments Download the PDF Sample
The GI segment was the largest segment and was valued at USD 643.40 million in 2018. Moreover, some of the findings through GI stool testing include digestion of food, types of bacteria in the gut, presence of dysbiosis, presence of parasites/worms, and strength of the immune system. In addition, some of the various reasons for GI stool testing, include hemorrhoids, peptic ulcers, inflammation in the esophagus, diverticulosis and diverticulitis, ulcerative colitis and Crohn's disease, colonic polyps, or cancer in the colon, stomach, or esophagus. Hence, factors such as the the increasing prevalence of chronic diseases coupled with the growing geriatric population fuels the growth of this segment which in turn drives the market growth during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. There has been an increase in the adoption of various advanced technologies for the treatment of GI bleeding in North America over the last few years. In addition, several factors such as the high adoption of technology, increasing prevalence and incidences of GI diseases, growing geriatric population, availability of reimbursement policies for endoscopic procedures, and the growing presence of prominent companies that develop endoscopic devices are significantly contributing to the growth of the market in the region. Furthermore, the increasing prevalence of chronic diseases such as stomach cancer, colon cancer, and pancreatic cancer fuels the need for GI bleeding treatment. Hence, such factors drive market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
BioMerieux SA: The company offers stool testing device which is designed to implement sample preparation for nucleic acid extraction of viruses, bacteria, and parasites
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Stool Testing Market Scope |
|
Report Coverage |
Details |
Page number |
165 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.92% |
Market growth 2024-2028 |
USD 445.95 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.41 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 40% |
Key countries |
US, Canada, UK, Germany, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AdvaCare Pharma, bioMerieux SA, Cardinal Health Inc., Cenogenics Corp., Danaher Corp., DiaSorin SpA, Eiken Chemical Co. Ltd., Epitope Diagnostics Inc., Exact Sciences Corp., Genova Diagnostics Inc., Helena Laboratories Corp., Hologic Inc., McKesson Corp., Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco CDP LLC, Quest Diagnostics Inc., Quidelortho Corp., CTK Biotech Inc., and ScheBo Biotech AG |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.